依普利酮可缓解原发性醛固酮增多症患者螺内酯诱发的疼痛性男性乳房发育症。 - Suppr

Suppr

超能文献

Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.

作者信息

Karagiannis Asterios, Tziomalos Konstantinos, Kakafika Anna, Florentin Matilda, Athyros Vassilios Gabriel

出版信息

Nephrol Dial Transplant. 2007 Jan;22(1):293. doi: 10.1093/ndt/gfl500. Epub 2006 Oct 2.

DOI:10.1093/ndt/gfl500

PMID:17018542

Abstract

摘要

相似文献

Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.

Nephrol Dial Transplant. 2007 Jan;22(1):293. doi: 10.1093/ndt/gfl500. Epub 2006 Oct 2.

Eplerenone relieves spironolactone-induced painful gynaecomastia in patients with decompensated hepatitis B-related cirrhosis.

Scand J Gastroenterol. 2007 Dec;42(12):1516-7. doi: 10.1080/00365520701676070.

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.

Expert Opin Pharmacother. 2008 Mar;9(4):509-15. doi: 10.1517/14656566.9.4.509.

Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.

Heart Dis. 2003 Sep-Oct;5(5):354-63. doi: 10.1097/01.hdx.0000089783.30450.cb.

Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension.

J Hypertens. 2013 Jan;31(1):3-15. doi: 10.1097/HJH.0b013e3283599b6a.

ARAs to the RESCUE.

J Am Soc Hypertens. 2016 Mar;10(3):187-8. doi: 10.1016/j.jash.2016.01.014.

The evolution of aldosterone antagonists.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):27-31. doi: 10.1016/j.mce.2003.10.005.

Eplerenone: cardiovascular protection.

Circulation. 2003 May 20;107(19):2512-8. doi: 10.1161/01.CIR.0000071081.35693.9A.

Eplerenone. Pharmacia.

Curr Opin Investig Drugs. 2003 Mar;4(3):316-22.

Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.

Horm Metab Res. 2018 May;50(5):375-382. doi: 10.1055/a-0604-3249. Epub 2018 May 3.

引用本文的文献

Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics.

Hepatol Int. 2011 Jun;5(2):738-9. doi: 10.1007/s12072-010-9235-x. Epub 2010 Dec 21.

Treatment of primary aldosteronism: Where are we now?

Rev Endocr Metab Disord. 2011 Mar;12(1):15-20. doi: 10.1007/s11154-011-9159-3.

Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.

Horm Metab Res. 2009 Jan;41(1):35-9. doi: 10.1055/s-0028-1087188. Epub 2008 Sep 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.

Nephrol Dial Transplant. 2007 Jan;22(1):293. doi: 10.1093/ndt/gfl500. Epub 2006 Oct 2.

Eplerenone relieves spironolactone-induced painful gynaecomastia in patients with decompensated hepatitis B-related cirrhosis.

Scand J Gastroenterol. 2007 Dec;42(12):1516-7. doi: 10.1080/00365520701676070.

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.

Expert Opin Pharmacother. 2008 Mar;9(4):509-15. doi: 10.1517/14656566.9.4.509.

Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.

Heart Dis. 2003 Sep-Oct;5(5):354-63. doi: 10.1097/01.hdx.0000089783.30450.cb.

Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension.

J Hypertens. 2013 Jan;31(1):3-15. doi: 10.1097/HJH.0b013e3283599b6a.

ARAs to the RESCUE.

J Am Soc Hypertens. 2016 Mar;10(3):187-8. doi: 10.1016/j.jash.2016.01.014.

The evolution of aldosterone antagonists.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):27-31. doi: 10.1016/j.mce.2003.10.005.

Eplerenone: cardiovascular protection.

Circulation. 2003 May 20;107(19):2512-8. doi: 10.1161/01.CIR.0000071081.35693.9A.

Eplerenone. Pharmacia.

Curr Opin Investig Drugs. 2003 Mar;4(3):316-22.

Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.

Horm Metab Res. 2018 May;50(5):375-382. doi: 10.1055/a-0604-3249. Epub 2018 May 3.

引用本文的文献

Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics.

Hepatol Int. 2011 Jun;5(2):738-9. doi: 10.1007/s12072-010-9235-x. Epub 2010 Dec 21.

Treatment of primary aldosteronism: Where are we now?

Rev Endocr Metab Disord. 2011 Mar;12(1):15-20. doi: 10.1007/s11154-011-9159-3.

Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.

Horm Metab Res. 2009 Jan;41(1):35-9. doi: 10.1055/s-0028-1087188. Epub 2008 Sep 25.